As a predictor of post-merger price competition, “willingness to pay” is a potentially powerful tool that federal antitrust agencies are increasingly relying on when assessing proposed hospital mergers. The agencies’ increasing reliance on the technique means that a thorough understanding of it is essential for attorneys involved in hospital merger transactions.
CRA Competition economists contribute to article-by-article commentary on the EU Foreign Subsidies Regulation
It gives the European Commission far-reaching powers to scrutinize financial contributions from non-EU governments to companies active in the EU, including in...